Our aim is to become a world leader in respiratory medicine, building on our reputation for providing the NHS with quality modified release preparations. Chiesi's UK operations are focussed on driving our success by meeting the needs of health professionals and helping them to improve outcomes for patients. Our highly trained and dynamic sales teams are fully equipped to provide a valued service to our customers. Our corporate product range consists of treatments for Asthma, COPD, Cystic Fibrosis, Ulcerative Colitis, Respiratory Distress Syndrome in premature babies and Apnoea in premature new-borns.
Number of employees:
Number of active countries: 60
Our comprehensive independent research revealed that Chiesi provides exceptional employee conditions, nurtures and develops talent throughout all levels of the organisation and has demonstrated its leadership status in the HR environment, always striving to optimise its employment practices and to develop its employees.
We help your organisation adapt to the rapidly changing HR environmentHow we certify